Pipeline Value Demonstration Manager (Fixed term)

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use.  I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

Job title: Pipeline Value Demonstration Manager (Fixed Term – 12 months)

Reports to: Head of Appraisals and Pipeline Value Demonstration

Department: Market Access and Pricing

Summary

The Pipeline Value Demonstration Manager brings together technical knowledge of cost-effectiveness methods used in health technology appraisal (HTA) and a broader awareness of market access and commercial strategy to help shape the development of Takeda’s innovative pipeline. This is a highly collaborative role interacting with multiple internal functions at the Local Operating Country (LOC), Regional, and Global level as well as externally with health care professionals (HCPs) and patient advocacy groups (PAGs) to deliver prioritised, strategic recommendations for pipeline programs. The role requires proactivity, strong interpersonal skills, and the ability to work on a broad range of projects as you work autonomously and as part of larger teams across a wide range of therapeutic areas.

Responsibilities

• Deliver prioritised, strategic recommendations on the evidence requirements for pipeline assets (Phase 1 onwards) to Global Program Teams, based on patient, payer, prescriber and LOC needs.
• Support the shaping of clinical development programmes and Global evidence generation plans to ensure the evidence required for patient access in the UK (and cost-effectiveness-driven markets generally) is incorporated and consistent with the overarching commercial strategy and product value proposition.

• Validate, stress test and advise on Global access strategy, pricing, and launch scenarios, identifying key risks and opportunities
• Collaborate with cost-effectiveness LOCs to understand, collect, and consolidate their key evidence needs for HTA across the Takeda pipeline.
• Provide strategic guidance and support in the planning and execution of evidence generation activities in the UK, EUCAN, Global, and other cost-effectiveness markets where appropriate (ensuring compliance with UK requirements, where necessary).
• Support in the identification and early engagement of HCPs, PAGs, health economists and HTA experts to inform Global and local strategy and build long term relationships with Takeda.
• Collaborate across functions (including New Product Planning) to drive early understanding of new disease backgrounds, therapeutic landscape, competitive intelligence, stakeholders, data sources and HTA landscape in the UK.
• Liaise across the UK and above country to ensure the UK Market Access team are kept informed regarding clinical development plans, evidence generation progress, launch timelines and regulatory pathways.
• Collaborate with Global and UK health economists to develop early economic models and support health economics-related activities; specifically, ensuring early modelling reflects the UK landscape and model scenarios can identify key model drivers and evidence gaps
• Lead priority early activities to support and enable broad, timely patient access to Takeda pipeline assets where appropriate (e.g. scientific advice, advisory boards, early access strategy development).
• Critique and/or run analyses and publish key scientific findings in high-impact journals, on topics including:
  • Meta-analysis/extensive statistical analysis
  • Outcome research
  • Indirect comparisons
  • Health economic modelling
• Deputise, as appropriate, for the Head of Appraisals and Pipeline Value Demonstration at both external and internal meetings.
• Ensure continuous knowledge transfer of early pipeline development and strategy initiatives through to teams responsible for HTA submissions.
• Therapeutic areas (Gastroenterology, Immunology, Neuroscience, Rare Diseases, Haematology)

Your profile 

• MSc or PhD in a scientific area (human biology, medicine, statistics, health economics, health policy)
• 3+ years of experience in the pharmaceutical industry/CRO in evidence generation (health economic modelling/ outcome research/ data analysis).
• Experience leading a diverse set of evidence generation activities (e.g. health economic modelling, RWE, indirect treatment
  comparisons, PRO development).
• Demonstrated experience collaborating with senior internal and external stakeholders and working across matrix teams.
• Experience leading development of multiple HTAs from planning through to successful decision
• Highly proactive, well organised and goal orientated with an excellent track record of meeting deadlines.
• Ability to make decisions and communicate rationale in high pressure environments.
• Ability to think strategically and see the big picture as well as being able to focus on the detail

Locations

Worker Type

Worker Sub-Type

Time Type